Principal Financial Group Inc Jaguar Health, Inc. Transaction History

Principal Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.27 - $0.71 $30,696 - $80,719	-113,690 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$0.38 - $1.07 $20,982 - $59,083	-55,218 Reduced 32.69%	113,690 $81,000
Q4 2021 Feb 09, 2022	SELL	$1.03 - $2.48 $231,070 - $556,363	-224,340 Reduced 57.05%	168,908 $176,000
Q3 2021 Nov 09, 2021	BUY	$2.14 - $4.95 $841,550 - $1.95 Million	393,248 New	393,248 $893,000

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $127M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.